Eamonn Hobbs

Eamonn Hobbs has a wealth of experience in the medical device and biopharmaceutical industries. Eamonn currently serves as the President & CEO of syncromune, a clinical stage biopharmaceutical company focused on developing personalized medicine for metastatic cancers. Prior to this, they founded Hobbs Medical Ventures, LLC, a consulting firm specializing in medical device and combination devices/pharmaceuticals.

Hobbs has also held roles as a Visiting Scholar and Entrepreneur in Residence at the Translational Accelerator at Brigham and Women's Hospital, as well as a Partner and Senior Client Advisor at BiotechExec. Eamonn has served on the board of directors for OraSure Technologies, a leader in point of care diagnostic and collection devices, and Harmonic Medical, a company involved in developing ultrasound-guided high intensity focused ultrasound therapy systems.

Additionally, Hobbs has been actively involved in the medical device industry as the Prior Chairman of the Board of Directors for the Medical Device Manufacturers Association. Eamonn has also held executive positions at Marvao Medical, where they served as Chairman of the Board of Directors, and ImmunSYS, Inc., where they were Chairman and CEO. At IlluminOss Medical Inc., Hobbs served as Executive Chairman and contributed to the development of a disruptive technology for the orthopedic trauma market.

Overall, Eamonn Hobbs's work experience demonstrates their expertise and success in various roles within the medical device and biopharmaceutical sectors.

Eamonn Hobbs attended the University of Massachusetts Lowell from 1976 to 1980. During this time, they pursued a Bachelor of Science degree in Plastics Engineering and specialized in the field of Bioengineering and Biomedical Engineering. Additionally, they obtained another Bachelor of Science degree in Plastics Engineering from the same university.